Fidelity International's 2026 outlook highlights Bitcoin's evolution from a speculative asset to a macro hedge amid escalating geopolitical tensions and fears of currency debasement. Institutional adoption is accelerating, with corporate treasuries, sovereign wealth funds, and private banks increasingly involved. Despite a significant 30% price drop in October 2025, Fidelity views this as modest compared to historical Bitcoin drawdowns. The report also notes Bitcoin's expanding roles in collateral, lending, and derivatives markets, supported by institutional-grade risk management and exchange-traded products, positioning it alongside traditional hedges like gold and inflation-linked bonds.
United Natural Foods (UNFI) is set to report Q4 earnings with revenue expected around $7.71 billion, a slight 1.6% decline from last year due to network optimization. Despite the revenue drop, EPS is forecasted to rise sharply to $0.61-$0.62, a signi...
Oracle reported strong fiscal 2026 results with 17% revenue growth to $67 billion and a 36% net income increase, driven by a 75% surge in its cloud infrastructure segment. Despite a recent 55% stock price drop from its peak, Morgan Stanley raised Ora...
RBC Capital increased its price target for cybersecurity firm Zscaler to $210, maintaining an "Outperform" rating due to the company's strong financial results and AI innovation. Zscaler reported a 25% rise in revenue and Annual Recurring Revenue, su...
Lululemon Athletica's shares fell about 18% after the company lowered its full-year financial forecast for the second time, reflecting ongoing challenges. In Q2 2026, total net revenue dropped 4% to $2.40 billion, with a 10% fall in comparable sales ...
Teva Pharmaceutical Industries received a boost as UBS reaffirmed its "Buy" rating and raised the price target to $48, up from $36.62. This follows positive Phase 2a clinical trial results for TEV '408, a drug showing significant prevention of intest...
